Overview

The Graduate Institute of Biomedical Electronics and Bioinformatics (abbreviated as BEBI) was established 1 August 2006. The Institute focuses on integrating Electrical Engineering and Information Engineering to conduct prospective academic study and interdisciplinary teaching. In other words, BEBI’s mission is to enhance the quality of interdisciplinary academic study and to aim to cope with the rapid development of biotechnology in recent years. BEBI’s research fields include Biomedical Electronics, Molecular/ Cell/ Tissue Imaging, Biomedical Signal Processing, Bio Photonics, Sensors, Micro-Array Analysis, Computer-Aided Diagnostics, Bioinformatics, Systems Biology and Medical Informatics, etc. In order to excel in these specialized field sand to seek potential cooperation opportunities, it is crucial to integrate professions across diverse research fields.
In August 2006, BEBI began enrolment for its doctoral program; 17 Doctoral candidates enroll in the program every year. Enrolment for the Master’s Program started in August 2007; 44 Master’s students (including 2 in-service program students) enroll in the program annually. BEBI now has 27 faculties with diverse field of study, including Electrical Engineering, Computer Science, Biology, Pharmacology, Biomedical Engineering and Life Sciences. The courses are designed to provide students with sufficient interdisciplinary training to meet the challenges of bioengineering development. BEBI’s current focus is to conduct an integrated study on key biomedical problems, industry issues, and offer interdisciplinary training programs. We look forward to the continued growth of BEBI and to making sound contributions to biotechnology and health care.

Bioengineering encompasses Biomaterials, Biomedicine, Mechanical and Biomedical Electronics, Biomedical Information, Biomedical Imaging, Bio Photonics and Clinical Engineering. BEBI continues to focus on prospective academic study, including Bioinformatics Research in the Post-Genomic Era, Nano Biomedical Technology, and Medical Science, and on technology required for the progressively aging society. The only way to enhance the technical level of the domestic biomedical industry and to develop talent is through the integration of research resources from inter disciplinary search fields and alignment with Government policy and direction. In accordance with research direction, BEBI focuses on the following subjects:

Nanotechnology and Biotechnology are the two most important research fields of the 21st century, and the integration of these two fields will bring significant breakthroughs to the biomedical industry. Nano Biomedical Technology can be defined as the study of Nano-sized materials, systems, diagnostics technology, and disease treatment and prevention. Developed countries are now placing significant resources in Nano Biomedical Study. BEBI will also target its resources in this research field and conduct prospective academic study in Targeted Drug Delivery, Nano-sized Molecular Imaging, Nano Electromechanical Technology, Bionic Nano Array Sensing Systems, and the Biological Efficacy of Nanomaterials, and enhance the precision of current biomedical diagnosis systems through Nano material electromagnetic wave properties, therefore making the system smaller and easier to personalize. The main research direction under this category is on the application of Nanotechnology and Biomedical Engineering. This includes Microchips, Implantable Sensing Systems and other real-time devices to collect patient information. This information can then be used to conduct real-time patient monitoring or remote medical services. In addition to the sensing system, Nano Biomedical Technology also covers a variety of biochips such as Lab-on-a-chip which enables efficient biochemistry and molecular biology analysis. The development of Lab-on-a-chip can also be integrated with pharmacological calculations to enable rapid and economic drug synthesis and analysis. The development of Nano Biomedical Technology can directly contribute to the revolution of the biomedical industry and add true value to the industry.

With regards to Bioinformatics, BEBI aims to integrate resources in the fields of Information Technology and Basic Biomedical Technology. BEBI will continue conducting prospective academic study in the areas of Data Analysis, Data Mining, Biomedical Computing Systems, Computational Pharmacology and Computational Chemistry to develop both Doctoral and Master level research personnel. In terms of Data Analysis and Data Mining, key research fields include Biochips, Information Analysis, DNA and Protein Analysis, Gene and Protein Structure and Function Analysis, as well as Data Mining. On Computational Pharmacology, the focus is on Basic Biomedical and Life Science Simulation System Models and its development of mathematical analysis to form the basis for the advanced analysis and simulation of biomedical and life sciences phenomena. In terms of Computational Chemistry, BEBI will focus on the Calculation of Quantum Chemical Calculations and Chemical Kinetics involved in drug and vaccine development to construct new computing models as well as more efficient algorithms for drug use.

With regards to Medical Information Systems, BEBI will focus on the integration of Information Technology and Clinical Teaching, and develop research personnel to conduct prospective academic study in areas such as Network Systems, Multimedia Systems, Database Systems, Parallel Computing, Distributed Computing, real-time computing hardware and software design, algorithms, and other issues regarding medical information.

With regards to Biochip and Biomedical Microelectronic Systems, our focus is on development and technological research in fields such as Biochips, Optical and Electronic Detection Technology, Digital Signal Processing, Image Recognition Technology and the interpretation and analysis of genomes. We also focus on the technological development of Bio Signal Sensing Microelectronics, MOEMS and electronic signal processing hardware and software design. This area of study also includes single-electron transistors, single-molecule spectroscopy and imaging tests, and microscopic spectral image measurement. BEBI will also manage to integrate resources from the Department of Electrical Engineering, Electrical Engineering, Computer Science, Photonics and Optoelectronics, Electronics Engineering, Communication Engineering, and the Department of Networking and Multimedia to develop miniaturized, non-invasive, wireless sensing, monitoring, and transmitting technology. The Leveraging System on Chip technology (SOC) is adopted to develop electronic equipment for biological measurements, medical diagnostics and for treatment purposes.

生here has been rapid development in Bio Photonics Technology, which aims to integrate the latest optical technology with the research and development of biomedical technology. The main research areas are semiconductor lasers design and applications, Nano or quantum biological sensing technology, optical components, spectroscopy or fluorescence spectroscopy in biomedical applications, optical microscopy imaging and analytical technologies. We use high-resolution microscopic imaging and optical manipulation technology to conduct genomics and proteomics-related studies. Moreover, the development of various biological identity and positioning technology enables early disease optical diagnosis and minimal invasive diagnosis. Related core technologies include biomedical fluorescence techniques, confocal microscopy, ultrafast laser technology, multi-photon laser scanning microscopy and biochip detection technology.

BEBI’s main focus is to develop bio-related electronic and information technology through integrating photovoltaic microelectronics, MOEMS, information, communications, and signal processing technology and to extend the application of biomedical engineering. By cooperating with the College of Medicine, Life Sciences, Bio-resources and Agriculture, Engineering, and the College of Sciences, we aim to pursue academic breakthroughs and contribute to the development of the domestic biomedical industry through technology transfer, licensing and cooperation mechanisms.